Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cardiovascular Systems, Inc. logo — company profile

Cardiovascular Systems, Inc.

Founded 1989 United States St. Paul, United States 343 employees Post Ipo Debt Total: $98.00M Biotechnology, Health Care +1

General Information

Company Name Cardiovascular Systems, Inc.
Founded Year 1989
Location United States St. Paul, United States +1
Founders / Decision Makers
Team member Team member Team member
Employees 343
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post Ipo Debt
Social

Get notified when Cardiovascular Systems, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cardiovascular Systems, Inc.

Cardiovascular Systems (CSI) is dedicated to providing innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). Founded in 1989 in the United States, their primary focus is on helping physicians overcome challenging disease states, including arterial calcium, for those suffering from PAD and Complex PCI. CSI emphasizes clinical rigor, constant innovation, and a commitment to setting the standard in safe, effective, and affordable medical devices that enhance patient outcomes. The company upholds Core Values of accountability, integrity, excellence, courage, velocity, and community, creating an invigorating work environment for its employees. It is important to note that CSI is committed to providing equal employment opportunities (EEO) and reasonable accommodations for individuals with disabilities, aligning with their value of community. Their vision is encapsulated in their mission of 'Saving Limbs. Saving Lives. Every Day.' The company received a $2.00M Post-IPO Debt investment on 12 March 2013. For more information, visit www.CSI360.com and connect with them on Twitter and Facebook. For safety information, refer to https:\/\/csi360.com\/indications-statements-important-safety-and-risk-information\/.

Taxonomy: vascular disease, peripheral artery disease, coronary artery disease, arterial calcium, clinical innovation, patient outcomes, equal employment opportunity, cardiovascular treatment, work environment, core values, safety information, EEO policy, Clinical rigor

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 12 Mar 2013
Post-IPO Debt •••••• - 22 Feb 2013
Post-IPO Debt •••••• - 12 Feb 2013
Post-IPO Debt •••••• - 29 Aug 2011
Post-IPO Debt •••••• - 09 Aug 2011

View All 12 Funding Rounds

Cardiovascular Systems, Inc. Alternatives & Competitors

Cardiovascular Systems, Inc. vs
HemoShear Therapeutics
HemoShear Therapeutics United States

Developing new treatments for rare metabolic disorders

Debt Financing
27 employees
Biotechnology, Health Care
Compare Cardiovascular Systems, Inc. vs HemoShear Therapeutics
Cardiovascular Systems, Inc. vs
Acton Medical Associates
Acton Medical Associates United States

High Quality Primary Care for Patients of All Ages - Independently Owned and Operated for 65 Years

150 employees
Health Care, Sports
Compare Cardiovascular Systems, Inc. vs Acton Medical Associates
Cardiovascular Systems, Inc. vs
Riverside Insights
Riverside Insights United States

Providing Insights That Elevate Potential

297 employees
Also compare with: Cardiovascular Systems, Inc. vs American Kidney Fund American Kidney Fund

FAQ About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is committed to providing innovative solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). Our primary focus is helping physicians conquer even the most difficult disease states, including the challenge of arteri...
Cardiovascular Systems, Inc. was founded in 1989.
Cardiovascular Systems, Inc. is headquartered in St. Paul, United States.
Cardiovascular Systems, Inc. operates in the following industries: Biotechnology, Health Care, Medical Devices.
Cardiovascular Systems, Inc. has approximately 343 employees.
Cardiovascular Systems, Inc. has completed 12 funding rounds, raising a total of $98.00M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Cardiovascular Systems, Inc. include HemoShear Therapeutics, Acton Medical Associates, Riverside Insights, American Kidney Fund, Acadia Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiovascular Systems, Inc. and HemoShear Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cardiovascular Systems, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes